Evidence map›Paper›PMID 30444560›Full record

ArticleChembiochem : a European journal of chemical biology2019

Reactivity of the Major Product of C5'-Oxidative DNA Damage in Nucleosome Core Particles.

Anup Rana, Kun Yang, Marc M Greenberg

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anup RanaDepartment of Chemistry, Johns Hopkins University, Baltimore, MD, 21218, USA.
Kun YangDepartment of Chemistry, Johns Hopkins University, Baltimore, MD, 21218, USA.
Marc M GreenbergDepartment of Chemistry, Johns Hopkins University, Baltimore, MD, 21218, USA.ORCID 0000-0002-5786-6118
Johns Hopkins University · US

Funding

Repair, Replication, and Detection of Oxidatively Damaged DNAR01GM063028 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI GREENBERG, MARC M · 2002 to 2018
$5.4M
Acquisition of GE Typhoon FLA9500 Variable Mode ImagerS10OD021567 · OD · JOHNS HOPKINS UNIVERSITY · PI MCCAFFERY, J. MICHAEL · 2017 to 2017
$147k
NIGMS NIH HHS R01 GM063028NIH HHS S10 OD021567
6 · The paper itself

Abstract

The major pathway for DNA damage following hydrogen atom abstraction from the C5'-position results in direct strand scission and concomitant formation of a 5'-aldehyde-containing nucleotide (e.g., T-al). We determined that the half-life of alkali-labile T-al in free DNA under physiological conditions varies from 5-12 days. T-al reactivity was examined at three positions within nucleosome core particles (NCPs). β-Elimination increased >2.5-fold when T-al was proximal to the lysine-rich histone H4 tail. No difference in reactivity between free DNA and NCPs was observed when T-al was distal from the histone tails. The position-dependent involvement of histone tails in T-al elimination was gleaned from experiments with sodium cyanoborohydride and histone protein variants. The enhancement of T-al elimination in NCPs is significantly smaller than previously observed for abasic sites. Computational studies comparing elimination from T-al and abasic sites indicate that the barrier for the rate-determining step in the latter is 2.6 kcal mol

Indexed as

BorohydridesDNAHistonesLysineModels, MolecularNucleic Acid ConformationNucleosomesOligonucleotidesOxidation-ReductionBorohydridesDNAHistonesLysineNucleosomesOligonucleotidessodium cyanoborohydrideDNA damageDNA oxidationmechanismnucleosome core particles

Identifiers

PMID30444560
PMCPMC6397081
OpenAlexW2900517922

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.